Vincent Elsermans

853 total citations
181 papers, 531 citations indexed

About

Vincent Elsermans is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Vincent Elsermans has authored 181 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Immunology, 38 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Vincent Elsermans's work include T-cell and B-cell Immunology (177 papers), Immune Cell Function and Interaction (166 papers) and Immunotherapy and Immune Responses (106 papers). Vincent Elsermans is often cited by papers focused on T-cell and B-cell Immunology (177 papers), Immune Cell Function and Interaction (166 papers) and Immunotherapy and Immune Responses (106 papers). Vincent Elsermans collaborates with scholars based in France, United Kingdom and Switzerland. Vincent Elsermans's co-authors include Isabelle Top, Jonathan Visentin, Marine Cargou, Gwendaline Guidicelli, Mamy Ralazamahaleo, Marco Andreani, Myriam Labalette, Pauline Varlet, Gérald Bertrand and Ibrahim Yakoub‐Agha and has published in prestigious journals such as Scientific Reports, Bone Marrow Transplantation and Clinical Transplantation.

In The Last Decade

Vincent Elsermans

164 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vincent Elsermans France	6	482	93	83	52	41	181	531
Marine Cargou France	6	477 1.0×	99 1.1×	53 0.6×	71 1.4×	3 0.1×	167	499
H.‐Y. Zou China	9	320 0.7×	73 0.8×	30 0.4×	64 1.2×	25 0.6×	118	355
Mamy Ralazamahaleo France	7	372 0.8×	56 0.6×	39 0.5×	56 1.1×	8 0.2×	70	412
Heather Kerr United Kingdom	6	146 0.3×	46 0.5×	29 0.3×	7 0.1×	47 1.1×	7	219
Gaëlle David France	13	368 0.8×	72 0.8×	15 0.2×	5 0.1×	87 2.1×	23	414
Tiffany Tse Canada	4	284 0.6×	90 1.0×	105 1.3×	5 0.1×	7 0.2×	12	375
Dimana Dimitrova United States	8	62 0.1×	30 0.3×	19 0.2×	9 0.2×	34 0.8×	26	135
Andy Roemhild Germany	10	113 0.2×	61 0.7×	20 0.2×	22 0.4×	17 0.4×	11	197
Lars Quist United States	2	129 0.3×	49 0.5×	18 0.2×	3 0.1×	19 0.5×	2	159
Juliana Silva United Kingdom	6	74 0.2×	103 1.1×	23 0.3×	14 0.3×	52 1.3×	10	222

Countries citing papers authored by Vincent Elsermans

Since Specialization

Citations

This map shows the geographic impact of Vincent Elsermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Elsermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Elsermans more than expected).

Fields of papers citing papers by Vincent Elsermans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Elsermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Elsermans. The network helps show where Vincent Elsermans may publish in the future.

Co-authorship network of co-authors of Vincent Elsermans

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Elsermans. A scholar is included among the top collaborators of Vincent Elsermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Elsermans. Vincent Elsermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elsermans, Vincent, et al.. (2025). Characterisation of the Novel HLA ‐C*16:01:01: 42Q Allele by Sequencing‐Based Typing. HLA. 105(5). e70229–e70229.

Elsermans, Vincent, et al.. (2025). Characterisation of the Novel HLA ‐A*68:322 Allele by Sequencing‐Based Typing. HLA. 105(5). e70230–e70230.

Cargou, Marine, et al.. (2025). Characterisation of the HLA‐DPB1*104:01:08 Allele by Sequencing‐Based Typing. HLA. 105(5). e70245–e70245.

Cargou, Marine, et al.. (2025). Characterisation of the Novel HLA ‐C*07:1173 Allele by Sequencing‐Based Typing. HLA. 105(4). e70186–e70186.

Elsermans, Vincent, et al.. (2025). Characterisation of the Novel HLA ‐ DPB1 *1783:01 Allele by Sequencing‐Based Typing. HLA. 105(5). e70235–e70235.

Elsermans, Vincent, et al.. (2025). Characterisation of the Novel HLA‐DQB1*05:357 Allele by Sequencing‐Based Typing. HLA. 105(5). e70269–e70269.

Cargou, Marine, et al.. (2025). Characterisation of the Novel HLA‐A*01:470 Allele by Sequencing‐Based Typing. HLA. 105(4). e70202–e70202.

Elsermans, Vincent, et al.. (2025). Characterisation of the Novel HLA ‐A*32:01:64 Allele by Sequencing‐Based Typing. HLA. 105(5). e70236–e70236.

Elsermans, Vincent, et al.. (2025). Characterisation of the Novel HLA‐A*68:331 Allele by Sequencing‐Based Typing. HLA. 105(5). e70221–e70221.

10.

Elsermans, Vincent, et al.. (2025). Characterisation of the Novel HLA‐C*07:1184 Allele by Sequencing‐Based Typing. HLA. 106(5). e70476–e70476.

11.

Elsermans, Vincent, et al.. (2025). Characterisation of the Novel HLA‐C*03:703 Allele by Sequencing‐Based Typing. HLA. 106(6). e70467–e70467.

12.

Elsermans, Vincent, et al.. (2025). Characterisation of the Novel HLA‐DQB1*05:311:02 Allele by Sequencing‐Based Typing. HLA. 105(3). e70115–e70115. 1 indexed citations

13.

Cargou, Marine, Vincent Elsermans, Isabelle Top, Gwendaline Guidicelli, & Jonathan Visentin. (2024). Characterisation of the novel HLA‐B*51:411 allele by sequencing‐based typing. HLA. 104(3). e15679–e15679. 2 indexed citations

14.

Cargou, Marine, Vincent Elsermans, Isabelle Top, Gwendaline Guidicelli, & Jonathan Visentin. (2024). Characterisation of the novel HLA‐A*26:247 allele by sequencing‐based typing. HLA. 104(3). e15673–e15673. 2 indexed citations

15.

Elsermans, Vincent, et al.. (2024). Characterization of the Novel HLA‐C*07:01:126 Allele by Sequencing‐Based Typing. HLA. 104(4). e15713–e15713. 1 indexed citations

16.

Cargou, Marine, et al.. (2024). Characterization of the novel HLA‐B*51:394Q allele by sequencing‐based typing. HLA. 103(2). e15404–e15404. 2 indexed citations

17.

Cargou, Marine, et al.. (2023). Characterization of the novel HLA‐A*24:587 allele by sequencing‐based typing. HLA. 102(2). 216–218. 2 indexed citations

18.

Cargou, Marine, et al.. (2023). Characterization of the novel HLA‐C*05:01:01:81Q allele by sequencing‐based typing. HLA. 102(1). 93–95. 1 indexed citations

19.

Elsermans, Vincent, et al.. (2023). Characterization of the novel HLA‐C*03:552 allele by sequencing‐based typing. HLA. 102(2). 237–238. 2 indexed citations

20.

Elsermans, Vincent, Jonathan Visentin, Marine Cargou, Isabelle Top, & Myriam Labalette. (2023). Characterization of the novel HLA‐C*06:176:02 allele by sequencing‐based typing. HLA. 103(1). e15253–e15253. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact